KFG
CRL icon

Kingdom Financial Group’s Charles River Laboratories CRL Stock Holding History

Kingdom Financial Group’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$3.1K Hold
18
– – ﹤0.01% 627
2025
Q4 		$3.59K Buy
+18
New +$3.27K ﹤0.01% 529

Other funds holding CRL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Kingdom Financial Group's CRL Position: Q1 2026 in Review

Kingdom Financial Group held its Charles River Laboratories (CRL) position steady in Q1 2026 at 18 shares worth $3.1K. The position accounts for ﹤0.01% of the portfolio, ranked #627.

Kingdom Financial Group first reported a position in CRL in Q4 2025 and has held it in 2 quarters since. The position peaked at $3.59K in Q4 2025. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Kingdom Financial Group held 18 shares of Charles River Laboratories worth $3.1K as of Q1 2026.
  • Kingdom Financial Group left its Charles River Laboratories share count unchanged in Q1 2026.
  • Charles River Laboratories made up ﹤0.01% of Kingdom Financial Group's portfolio in Q1 2026, its #627 holding.
  • Kingdom Financial Group first reported a position in Charles River Laboratories in Q4 2025 and has held it in 2 quarters since.
  • Kingdom Financial Group's Charles River Laboratories position peaked at $3.59K in Q4 2025.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Kingdom Financial Group's 13F filing for Q1 2026, filed 13 May 2026.